What is PRRUF's gross margin?

Immutep (PRRUF) has a gross margin of 90% and a net margin of -329%.

What is PRRUF's P/E ratio?

Track Immutep (PRRUF) P/E ratio, ROE, and valuation metrics over time.

Where can I see PRRUF's full financials?

See Immutep (PRRUF) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Immutep (PRRUF) Financials — Revenue, Earnings, Cash Flow

$0.03

+0.00 (+0.00%)

OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 39 · $44.2M mcap · 1.43B float · 0.0000% daily turnover · Short 74% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$19M

Revenue

+153.6% YoY

$-121M

Net Income

-46.6% YoY

$-92M

Free Cash Flow

-205.5% YoY

89.9%

Gross Margin

-372.2%

Op. Margin

-328.8%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-96.5%

ROA-85.1%

ROIC2212.5%

Valuation

P/E-0.6

P/B0.8

EV/EBITDA0.0

Leverage

Debt/Equity0.02

Current Ratio5.69

Interest Cov.-1640.4x

Quality Scores

Piotroski F3/9

Altman Z—

Beneish M-8.32